Development of New Software Capabilities for Use With Cardiovascular Magnetic Resonance Imaging (CVMRI)
This Protocol is intended to facilitate development and testing of new cardiovascular MRI software capabilities by UC Davis Research Faculty, as well as to facilitate the evaluation of new software capabilities provided by GE and Siemens.
|Study Design:||Observational Model: Case Control
Time Perspective: Prospective
|Official Title:||Development of New Software Capabilities for Use With Cardiovascular Magnetic Resonance Imaging|
- Extend or generalize certain capabilities, such as new data acquisition pulse sequences, new image processing and analysis software for structural and functional analysis of the MR images [ Time Frame: Post-scanning ] [ Designated as safety issue: No ]
- Improve image quality by various techniques (e.g. reducing the effects of motion) [ Time Frame: Post-scanning ] [ Designated as safety issue: No ]
|Study Start Date:||May 1999|
|Estimated Study Completion Date:||January 2015|
|Estimated Primary Completion Date:||January 2015 (Final data collection date for primary outcome measure)|
This protocol will permit normal subjects, as well as patients with suspected or proven medical conditions, to undergo MRI studies using the new software capabilities. This Protocol is not restricted to imaging of a particular organ system or disease. The Protocol does not involve injection of any contrast agent, or other minimally-invasive or invasive procedure. It is intended only for those cases for which the only requirement of the subject is to relax and lie still while imaging is being performed.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00593541
|Principal Investigator:||Michael H Buonocore, MD, PhD||University of California, Davis|